Atrion (NASDAQ:ATRI) Shares Gap Up to $620.93

Atrion Co. (NASDAQ:ATRIGet Rating)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $620.93, but opened at $636.90. Atrion shares last traded at $616.03, with a volume of 2 shares traded.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Atrion from a “buy” rating to a “hold” rating in a report on Tuesday, November 8th.

Atrion Stock Down 3.4 %

The business’s 50 day moving average is $603.47 and its two-hundred day moving average is $621.36. The firm has a market capitalization of $1.07 billion, a P/E ratio of 31.27 and a beta of 0.28.

Atrion Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 15th. Shareholders of record on Thursday, December 1st will be issued a dividend of $2.15 per share. The ex-dividend date of this dividend is Wednesday, November 30th. This represents a $8.60 annualized dividend and a yield of 1.42%. Atrion’s payout ratio is presently 44.44%.

Insiders Place Their Bets

In related news, CFO Jeffery Strickland sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 26th. The stock was sold at an average price of $675.00, for a total value of $675,000.00. Following the completion of the sale, the chief financial officer now owns 1,532 shares of the company’s stock, valued at approximately $1,034,100. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 22.65% of the company’s stock.

Institutional Investors Weigh In On Atrion

Several large investors have recently made changes to their positions in ATRI. HM Payson & Co. bought a new stake in Atrion during the first quarter worth approximately $26,000. Quantbot Technologies LP bought a new stake in Atrion during the third quarter worth approximately $29,000. Steward Partners Investment Advisory LLC bought a new stake in Atrion during the first quarter worth approximately $34,000. Nisa Investment Advisors LLC bought a new stake in Atrion during the first quarter worth approximately $36,000. Finally, Great West Life Assurance Co. Can bought a new stake in Atrion during the third quarter worth approximately $52,000. Institutional investors own 65.68% of the company’s stock.

About Atrion

(Get Rating)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Featured Stories

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.